Venture Planning Group- The 2011 US Cancer Diagnostics Market

?

Venture Planning Group (VPGMarketResearch.com) published a new diagnostics market research and technology assessment report, "The 2011 US Cancer Diagnostics Market ."

Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce completion of a new 620-page report, ?The 2011 US Cancer Diagnostics Market " (http://www.vpgmarketresearch.com/cancer.html). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the US cancer diagnostics market during this decade. This report presents a comprehensive analysis of the US cancer diagnostics market, including: ?Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ?Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ?Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics. ?Placements and installed base of automated and semiautomated analyzers used for cancer testing. ?Current instrumentation technologies and feature comparison of leading analyzers. ?Sales and market shares of leading suppliers. ?Emerging diagnostic technologies and their potential market applications. ?Product development opportunities. ?Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ?Business opportunities and strategic recommendations for suppliers. Contains 620 pages and 103 tables. To review or order this report, please visit http://www.vpgmarketresearch.com/the-us-cancer-diagnosti ... Contact Robert Fisher Healthcare Research robert@vpgcorp.com +1 212 564 2838 http://www.VPGMarketResearch.com Related Tags: US cancer diagnostics market ,? tumor markers ,? US cancer testing market ,? tumor marker testing ,? cancer diagnosis market

About the author Venture Planning Group is an international market research, publishing and management consulting firm providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavor & Fragrance, Food & Beverage, Electronics and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a worldwide network of contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. Specialties Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations

Syndicate this article? <strong>Posted By: </strong>vpgcorp<p>Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce completion of a new 620-page report, ?The 2011 US Cancer Diagnostics Market " <br/>(<span>http://www.vpgmarketresearch.com/cancer.html</span>). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the US cancer diagnostics market during this decade. </p><p>This report presents a comprehensive analysis of the US cancer diagnostics market, including: <br/>?Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.<br/>?Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.<br/>?Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics.<br/>?Placements and installed base of automated and semiautomated analyzers used for cancer testing. <br/>?Current instrumentation technologies and feature comparison of leading analyzers.<br/>?Sales and market shares of leading suppliers.<br/>?Emerging diagnostic technologies and their potential market applications.<br/>?Product development opportunities.<br/>?Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.<br/>?Business opportunities and strategic recommendations for suppliers. </p><p>Contains 620 pages and 103 tables.</p><p>To review or order this report, please visit <span>http://www.vpgmarketresearch.com/the-us-cancer-diagnosti ...</span></p><p>Contact </p><p>Robert Fisher <br/>Healthcare Research <br/>robert@vpgcorp.com <br/>+1 212 564 2838 <br/><span>http://www.VPGMarketResearch.com</span></p><p><b>About the Author:</b> Venture Planning Group is an international market research, publishing and management consulting firm providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavor & Fragrance, Food & Beverage, Electronics and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a worldwide network of contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. Specialties Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations </p><p><b>Article Source:</b> http://www.articleshub.org/article/116061/Venture-Planning-Group--The-2011-US-Cancer-Diagnostics-Market.html</p>

Comments No Comments Yet!

Source: http://www.articleshub.org/article/116061/Venture-Planning-Group--The-2011-US-Cancer-Diagnostics-Market.html

washington post eyewitness news earthlink associated press breaking news usa today hcg diet